CRISPR-Based Delivery System Generates CAR T Cells In Vivo
A two-vector delivery system generates tumor-targeting CAR T cells directly inside the body, achieving complete responses in mouse cancer models
False
A two-vector delivery system generates tumor-targeting CAR T cells directly inside the body, achieving complete responses in mouse cancer models
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
August 13, 2025
1 min read
From standardizing CAR-T manufacturing to blockchain-backed data sharing, this roundtable tackles what it takes to scale life-saving advanced therapies.
August 12, 2025
5 min read
Academic medical centers are racing to adapt as political turnover and funding uncertainty threaten the future of cell and gene therapy research.
August 11, 2025
2 min read
The trial will continue, but development activities associated with a monoclonal antibody are to be discontinued
August 4, 2025
5 min read
FDA investigations, shipments holds, a resignation at the FDA and a negative opinion in Europe… I look into the recent controversy
False
Affiliations:
Specialties:
Areas of Expertise: